Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2005 Jun;60(6):517–520. doi: 10.1136/thx.2004.027953

Antibiotic allergy in cystic fibrosis

J Parmar 1, S Nasser 1
PMCID: PMC1747437  PMID: 15923254

Abstract

Allergic reactions to antibiotics are more common in cystic fibrosis (CF) than in the general population. This in part is due to the improving survival in adults with CF and the increased use of high dose intravenous antibiotics. While some are immediate anaphylaxis type (IgE mediated) reactions, the majority are late onset and may have non-specific features such as rash and fever. Piperacillin has consistently been found to have the highest rate of reported reactions (30–50%). There is a low risk of cross reactions between penicillins and other non-ß-lactam classes of antibiotics in penicillin skin prick positive patients. Carbapenems should only be used with extreme caution in patients with positive skin prick tests to penicillin. However, aztreonam can be used safely in patients who are penicillin allergic with positive skin prick reactions. The aminoglycosides are a relatively uncommon cause of allergic reactions, but patients who react to one member of the family may cross react with other aminoglycosides. Desensitisation relies on the incremental introduction of small quantities of the allergen and has been used for penicillins, ceftazidime, tobramycin and ciprofloxacin and must be repeated before each course. Personalised cards should be regularly updated for patients who develop allergic reactions. Written instructions on the emergency treatment of allergic reactions should be provided to patients self-administering intravenous antibiotics at home. Further research is required to identify risk factors and predictors for antibiotic allergy.

Full Text

The Full Text of this article is available as a PDF (86.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assem E. S., Vickers M. R. Tests for penicillin allergy in man. II. The immunological cross-reaction between penicillins and cephalosporins. Immunology. 1974 Aug;27(2):255–269. [PMC free article] [PubMed] [Google Scholar]
  2. Audicana M., Bernaola G., Urrutia I., Echechipia S., Gastaminza G., Muñoz D., Fernández E., Fernández de Corres L. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin. Allergy. 1994 Feb;49(2):108–113. doi: 10.1111/j.1398-9995.1994.tb00809.x. [DOI] [PubMed] [Google Scholar]
  3. Baldo Brian A., Pham Nghia H. Immunoglobulin E binding determinants on beta-lactam drugs. Curr Opin Allergy Clin Immunol. 2002 Aug;2(4):297–300. doi: 10.1097/00130832-200208000-00002. [DOI] [PubMed] [Google Scholar]
  4. Bals R., Weiner D. J., Wilson J. M. The innate immune system in cystic fibrosis lung disease. J Clin Invest. 1999 Feb;103(3):303–307. doi: 10.1172/JCI6277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blanca M., Fernandez J., Miranda A., Terrados S., Torres M. J., Vega J. M., Avila M. J., Perez E., Garcia J. J., Suau R. Cross-reactivity between penicillins and cephalosporins: clinical and immunologic studies. J Allergy Clin Immunol. 1989 Feb;83(2 Pt 1):381–385. doi: 10.1016/0091-6749(89)90122-x. [DOI] [PubMed] [Google Scholar]
  6. Burrows Judith A., Toon Michael, Bell Scott C. Antibiotic desensitization in adults with cystic fibrosis. Respirology. 2003 Sep;8(3):359–364. doi: 10.1046/j.1440-1843.2003.00461.x. [DOI] [PubMed] [Google Scholar]
  7. Earl H. S., Sullivan T. J. Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics. J Allergy Clin Immunol. 1987 Mar;79(3):477–483. doi: 10.1016/0091-6749(87)90365-4. [DOI] [PubMed] [Google Scholar]
  8. Equi A., Balfour-Lynn I. M., Bush A., Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet. 2002 Sep 28;360(9338):978–984. doi: 10.1016/s0140-6736(02)11081-6. [DOI] [PubMed] [Google Scholar]
  9. Ghosal S., Taylor C. J. Intravenous desensitization to ceftazidime in cystic fibrosis patients. J Antimicrob Chemother. 1997 Apr;39(4):556–557. doi: 10.1093/jac/39.4.556. [DOI] [PubMed] [Google Scholar]
  10. Girard J. P. Common antigenic determinants of penicillin G, ampicillin and the cephalosporins demonstrated in men. Int Arch Allergy Appl Immunol. 1968;33(5):428–438. doi: 10.1159/000230058. [DOI] [PubMed] [Google Scholar]
  11. Griesenbach U., Geddes D. M., Alton E. W. The pathogenic consequences of a single mutated CFTR gene. Thorax. 1999 Aug;54 (Suppl 2):S19–S23. doi: 10.1136/thx.54.2008.s19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jensen T., Pedersen S. S., Høiby N., Koch C. Safety of aztreonam in patients with cystic fibrosis and allergy to beta-lactam antibiotics. Rev Infect Dis. 1991 May-Jun;13 (Suppl 7):S594–S597. doi: 10.1093/clinids/13.supplement_7.s594. [DOI] [PubMed] [Google Scholar]
  13. Koch C., Hjelt K., Pedersen S. S., Jensen E. T., Jensen T., Lanng S., Valerius N. H., Pedersen M., Høiby N. Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses. Rev Infect Dis. 1991 May-Jun;13 (Suppl 7):S608–S611. doi: 10.1093/clinids/13.supplement_7.s608. [DOI] [PubMed] [Google Scholar]
  14. Lantner R. R. Ciprofloxacin desensitization in a patient with cystic fibrosis. J Allergy Clin Immunol. 1995 Dec;96(6 Pt 1):1001–1002. doi: 10.1016/s0091-6749(95)70240-7. [DOI] [PubMed] [Google Scholar]
  15. Mahadeva R., Webb K., Westerbeek R. C., Carroll N. R., Dodd M. E., Bilton D., Lomas D. A. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998 Jun 13;316(7147):1771–1775. doi: 10.1136/bmj.316.7147.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McDonnell T. J., FitzGerald M. X. Cystic fibrosis and penicillin hypersensitivity. Lancet. 1984 Jun 9;1(8389):1301–1302. doi: 10.1016/s0140-6736(84)92487-5. [DOI] [PubMed] [Google Scholar]
  17. Moss R. B., McClelland E., Williams R. R., Hilman B. C., Rubio T., Adkinson N. F. Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and/or cephalosporin antibiotics. Rev Infect Dis. 1991 May-Jun;13 (Suppl 7):S598–S607. doi: 10.1093/clinids/13.supplement_7.s598. [DOI] [PubMed] [Google Scholar]
  18. Novalbos A., Sastre J., Cuesta J., De Las Heras M., Lluch-Bernal M., Bombín C., Quirce S. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy. 2001 Mar;31(3):438–443. doi: 10.1046/j.1365-2222.2001.00992.x. [DOI] [PubMed] [Google Scholar]
  19. Peirce T. H., Vig S. J., Ingram P. M. Ceftazidime in the treatment of lower respiratory tract infection. J Antimicrob Chemother. 1983 Jul;12 (Suppl A):21–25. doi: 10.1093/jac/12.suppl_a.21. [DOI] [PubMed] [Google Scholar]
  20. Pichler Werner J. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003 Oct 21;139(8):683–693. doi: 10.7326/0003-4819-139-8-200310210-00012. [DOI] [PubMed] [Google Scholar]
  21. Pleasants R. A., Walker T. R., Samuelson W. M. Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis. Chest. 1994 Oct;106(4):1124–1128. doi: 10.1378/chest.106.4.1124. [DOI] [PubMed] [Google Scholar]
  22. Ramesh Sujatha. Antibiotic hypersensitivity in patients with CF. Clin Rev Allergy Immunol. 2002 Aug;23(1):123–141. doi: 10.1385/CRIAI:23:1:123. [DOI] [PubMed] [Google Scholar]
  23. Romano A., Mayorga C., Torres M. J., Artesani M. C., Suau R., Sánchez F., Pérez E., Venuti A., Blanca M. Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses. J Allergy Clin Immunol. 2000 Dec;106(6):1177–1183. doi: 10.1067/mai.2000.111147. [DOI] [PubMed] [Google Scholar]
  24. Saiman Lisa, Marshall Bruce C., Mayer-Hamblett Nicole, Burns Jane L., Quittner Alexandra L., Cibene Debra A., Coquillette Sarah, Fieberg Ann Yunker, Accurso Frank J., Campbell Preston W., 3rd Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2003 Oct 1;290(13):1749–1756. doi: 10.1001/jama.290.13.1749. [DOI] [PubMed] [Google Scholar]
  25. Sastre J., Quijano L. D., Novalbos A., Hernandez G., Cuesta J., de las Heras M., Lluch M., Fernandez M. Clinical cross-reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin. Allergy. 1996 Jun;51(6):383–386. [PubMed] [Google Scholar]
  26. Saxon A., Beall G. N., Rohr A. S., Adelman D. C. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med. 1987 Aug;107(2):204–215. doi: 10.7326/0003-4819-107-2-204. [DOI] [PubMed] [Google Scholar]
  27. Schretlen-Doherty J. S., Troutman W. G. Tobramycin-induced hypersensitivity reaction. Ann Pharmacother. 1995 Jul-Aug;29(7-8):704–706. doi: 10.1177/106002809502907-810. [DOI] [PubMed] [Google Scholar]
  28. Sheppard D. N., Welsh M. J. Structure and function of the CFTR chloride channel. Physiol Rev. 1999 Jan;79(1 Suppl):S23–S45. doi: 10.1152/physrev.1999.79.1.S23. [DOI] [PubMed] [Google Scholar]
  29. Solley G. O., Gleich G. J., Van Dellen R. G. Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol. 1982 Feb;69(2):238–244. doi: 10.1016/0091-6749(82)90105-1. [DOI] [PubMed] [Google Scholar]
  30. Spigarelli Michael G., Hurwitz Martin E., Nasr Samya Z. Hypersensitivity to inhaled TOBI following reaction to gentamicin. Pediatr Pulmonol. 2002 Apr;33(4):311–314. doi: 10.1002/ppul.10049. [DOI] [PubMed] [Google Scholar]
  31. Torres M. J., Mayorga C., Pamies R., Rodriquez J. L., Juarez C., Romano A., Blanca M. Immunologic response to different determinants of benzylpenicillin, amoxicillin, and ampicillin. Comparison between urticaria and anaphylactic shock. Allergy. 1999 Sep;54(9):936–943. doi: 10.1034/j.1398-9995.1999.00175.x. [DOI] [PubMed] [Google Scholar]
  32. Warner J. O., Taylor B. W., Norman A. P., Soothill J. F. Association of cystic fibrosis with allergy. Arch Dis Child. 1976 Jul;51(7):507–511. doi: 10.1136/adc.51.7.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wills R., Henry R. L., Francis J. L. Antibiotic hypersensitivity reactions in cystic fibrosis. J Paediatr Child Health. 1998 Aug;34(4):325–329. doi: 10.1046/j.1440-1754.1998.00197.x. [DOI] [PubMed] [Google Scholar]
  34. Wilson Diana L., Owens Robert C., Jr, Zuckerman Jonathan B. Successful meropenem desensitization in a patient with cystic fibrosis. Ann Pharmacother. 2003 Oct;37(10):1424–1428. doi: 10.1345/aph.1D022. [DOI] [PubMed] [Google Scholar]
  35. Wolter J., Seeney S., Bell S., Bowler S., Masel P., McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax. 2002 Mar;57(3):212–216. doi: 10.1136/thorax.57.3.212. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Web-only tables]
thorax_60_6_517__index.html (954B, html)
thorax_60_6_517__1.pdf (43.6KB, pdf)

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES